Can amyloidosis cause an itchy rash?

Can Amyloidosis Cause an Itchy Rash?

Yes, amyloidosis can cause an itchy rash, but only specific subtypes—primary localized cutaneous amyloidosis (PLCA), including lichen amyloidosis and macular amyloidosis—present with pruritic skin lesions, while systemic AL amyloidosis (the more common and severe form) does not typically cause skin manifestations.

Understanding the Two Distinct Entities

The critical distinction here is between systemic AL amyloidosis and primary localized cutaneous amyloidosis (PLCA):

Systemic AL Amyloidosis (The More Common, Life-Threatening Form)

• Does NOT typically cause itchy rashes 1, 2
• Primarily affects internal organs: heart (most prognostically important), kidneys, GI tract, liver, and nervous system 1, 2
• Median of 2 organs involved at diagnosis 1
• Caused by plasma cell dyscrasia producing misfolded immunoglobulin light chains 2, 3
• Requires urgent systemic treatment with daratumumab-based regimens 3

Primary Localized Cutaneous Amyloidosis (PLCA)

• Does cause intensely pruritic (itchy) skin lesions 4, 5, 6, 7
• Two main subtypes:
  • Lichen amyloidosis: Multiple infiltrated, hyperkeratotic papules, often on extremities and scapular areas 6, 8
  • Macular amyloidosis: Hyperpigmented patches, commonly on the back 6, 7
  • Biphasic amyloidosis: Both patterns present simultaneously 6, 7
• Amyloid deposits are keratin-derived, NOT immunoglobulin-derived 8
• Prevalent in Southern Chinese and South American populations 5
• Chronic condition with debilitating pruritus as the primary symptom 5

Pathophysiology of Pruritus in Cutaneous Amyloidosis

The severe itching in PLCA is associated with small-fiber neuropathy and hypersensitivity of cutaneous nerve fibers 5. Key findings include:

• Reduced intraepidermal nerve fiber counts 5
• Increased expression of IL-31 receptors (IL-31RA and OSMRβ) in the epidermis 5
• Elevated warm detection thresholds that correlate with itch severity 5

Clinical Presentation Clues

If you see an itchy rash with amyloidosis, look for:

• Well-demarcated plaques with infiltrated papules, often scapular region 6, 8
• Hyperpigmented patches on the back 6, 7
• Long-standing (years), intensely pruritic lesions 6, 7
• Resistance to antihistamines and topical corticosteroids 7
• Possible association with atopic dermatitis 4
• Rare association with MEN 2a syndrome (autosomal dominant) 8

Treatment Approach for Pruritic Cutaneous Amyloidosis

For PLCA with severe pruritus, consider these evidence-based options:

1. Tofacitinib (JAK inhibitor): 10 mg/day showed significant improvement in pruritus (PP-NRS), body surface area, and IGA scores at 4 weeks with good tolerability 9

2. Dupilumab: Particularly effective when PLCA coexists with atopic dermatitis; 600 mg initial dose, then 300 mg every 2 weeks produced marked improvement 4

3. Acitretin (oral retinoid): Demonstrated effectiveness in widespread biphasic amyloidosis with resolution of symptoms 7

Critical Pitfall to Avoid

Do not confuse cutaneous amyloidosis with systemic AL amyloidosis. If a patient presents with what appears to be cutaneous amyloidosis:

• Perform tissue biopsy with Congo red staining 3
• Use laser capture mass spectroscopy to determine if amyloid is keratin-derived (cutaneous) or immunoglobulin-derived (systemic) 3
• If systemic AL amyloidosis is confirmed, immediately evaluate for cardiac, renal, and other organ involvement with NT-proBNP, troponin, and free light chain assays 3
• Systemic AL amyloidosis requires urgent hematologic treatment, not dermatologic management 3

The presence of an itchy rash makes systemic AL amyloidosis highly unlikely and should direct your workup toward primary cutaneous forms.